Gross Profit Comparison: Biogen Inc. and Bio-Techne Corporation Trends

Biogen vs. Bio-Techne: A Decade of Diverging Profits

__timestampBio-Techne CorporationBiogen Inc.
Wednesday, January 1, 20142514110008532288000
Thursday, January 1, 20153072770009523400000
Friday, January 1, 20163366590009970100000
Sunday, January 1, 201737454100010643900000
Monday, January 1, 201843214300011636600000
Tuesday, January 1, 201947349100012422500000
Wednesday, January 1, 202048319400011639400000
Friday, January 1, 20216328500008872000000
Saturday, January 1, 20227564960007895100000
Sunday, January 1, 20237698150007302200000
Monday, January 1, 20247697250009675900000
Loading chart...

Unleashing insights

A Tale of Two Biotech Giants: Biogen Inc. vs. Bio-Techne Corporation

In the ever-evolving world of biotechnology, two companies have consistently captured the spotlight: Biogen Inc. and Bio-Techne Corporation. Over the past decade, these industry titans have showcased contrasting trajectories in their gross profit trends. From 2014 to 2023, Biogen Inc. experienced a notable decline in gross profit, dropping from a peak in 2019 to a 41% decrease by 2023. Meanwhile, Bio-Techne Corporation demonstrated a robust growth trajectory, with its gross profit nearly tripling over the same period.

This divergence highlights the dynamic nature of the biotech sector, where innovation and strategic decisions can lead to vastly different financial outcomes. As we look to the future, the absence of Biogen's 2024 data leaves room for speculation, while Bio-Techne's consistent upward trend suggests a promising path ahead.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025